Showing results (581-590 of 836) with videos related to

Sort By:
Pageof 84
Mbio|June 15, 2026
A screen of chromatin-targeting compounds identifies TAF1 as a novel regulator of HIV latencySamuel D Burgos, Airlie M Ward, Manickam Ashokkumar, et al.
International Psychogeriatrics|May 16, 2001
Quality of life for people with dementia living in residential and nursing home care: the impact of performance on activities of daily living, behavioral and psychological symptoms, language skills, and psychotropic drugsC Ballard, J O'Brien, I James, et al.
Molecular Cell|July 19, 2025
Structural mechanism of H3K27 demethylation and crosstalk with heterochromatin markersChien-Chu Lin, Yani Zhao, Caroline A Foley, et al.
Nature Communications|March 11, 2021
Single cell transcriptomic analysis of murine lung development on hyperoxia-induced damageMaria Hurskainen, Ivana Mižíková, David P Cook, et al.
Trials|September 24, 2013
Lifestyle Matters for maintenance of health and wellbeing in people aged 65 years and over: study protocol for a randomised controlled trialKirsty Sprange, Gail A Mountain, John Brazier, et al.
Autophagy|February 16, 2021
Identification of novel lipid droplet factors that regulate lipophagy and cholesterol efflux in macrophage foam cellsSabrina Robichaud, Garrett Fairman, Viyashini Vijithakumar, et al.
Biology of Reproduction|July 27, 2019
COX2 is induced in the ovarian epithelium during ovulatory wound repair and promotes cell survival†Lauren E Carter, David P Cook, Olga Collins, et al.
Stem Cells (Dayton, Ohio)|April 21, 2022
Single-Cell RNA Sequencing-Based Characterization of Resident Lung Mesenchymal Stromal Cells in Bronchopulmonary DysplasiaIvana Mižíková, Flore Lesage, Chanele Cyr-Depauw, et al.
Communications Biology|May 6, 2021
Transcriptional heterogeneity of stemness phenotypes in the ovarian epitheliumLauren E Carter, David P Cook, Curtis W McCloskey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research CouncilR de Wit, J T Roberts, P M Wilkinson, et al.
Pageof 84